ALBEMARLE CORP News
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
see moreALBEMARLE CORP Market News
13d
Albemarle Upside: Lithium Rally Spurs Upgrades Now
- Albemarle (ALB) saw mixed near-term results but clear strategic progress this week: analyst upgrades on stronger lithium pricing, a portfolio reshuffle via the Ketjen transaction, and Q4 execution issues that triggered a sharp share reaction. These concrete events sharpen ALB’s risk/reward for investors.
27d
Albemarle Idles Kemerton; Analysts Boost Targets!!
Albemarle placed its Kemerton lithium refinery into care and maintenance while reporting modest Q4 improvement that still missed EPS expectations. Despite the operational retrenchment, analysts have raised price targets as lithium prices surge, creating a contrast between near-term cost curtailment and medium-term demand optimism for ALB stock.
16 Feb at 04:00
Albemarle Shuts Kemerton, Lifts 2026 Guidance Now.
Albemarle reported narrower Q4 losses and higher sales, announced a full shutdown of its Kemerton lithium refinery in Australia, and issued bullish 2026 guidance predicated on stronger lithium prices. Analysts raised price targets and the stock rallied on the news. This article distills the key figures, operational rationale, analyst reactions, and what investors should watch next.
09 Feb at 04:00
Albemarle Q4: ALB Faces Volatility, Rally Doubt...
Albemarle (ALB) enters a pivotal week as Q4 results on Feb 11, 2026, and an earnings call on Feb 12 will test lofty expectations. Recent sharp price swings, elevated valuation, and consensus targets (including a $221M adjusted EBITDA hurdle) set the stage for outsized stock reactions tied to lithium pricing and cash flow metrics.